Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2014, Article ID 607145, 5 pages
http://dx.doi.org/10.1155/2014/607145
Clinical Study

The Therapeutic Effectiveness of the Coadministration of Weekly Risedronate and Proton Pump Inhibitor in Osteoporosis Treatment

1Department of Orthopaedic Surgery, Kawakita General Hospital, 1-7-3 Asagaya-kita, Suginami-ku, Tokyo 166-8588, Japan
2Department of Orthopaedic Surgery, Sakurakai Hospital, 2-13-1 Senju Sakuragi, Adachi-ku, Tokyo 120-0045, Japan
3Department of Inorganic Materials, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Chiyoda, Tokyo 101-0062, Japan

Received 28 July 2014; Revised 11 October 2014; Accepted 12 October 2014; Published 9 November 2014

Academic Editor: Jun Iwamoto

Copyright © 2014 Mizue Tanaka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Mizue Tanaka, Soichiro Itoh, Taro Yoshioka, and Kimihiro Yamashita, “The Therapeutic Effectiveness of the Coadministration of Weekly Risedronate and Proton Pump Inhibitor in Osteoporosis Treatment,” Journal of Osteoporosis, vol. 2014, Article ID 607145, 5 pages, 2014. https://doi.org/10.1155/2014/607145.